Lumefantrine is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with artemether for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infe...
Lumefantrine and artemether combination therapy is indicated for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum, including malaria acquired in chloroquine-resistant areas. May also be used to treat uncomplicated malaria when the Plasmodium species has not been identified. Indicated for use in adults and children greater than 5 k...
Chikankata Health Services, Chikankata, Southern Province, Zambia
Cameroon Baptist Convention Clinic of Biyem-Assi, Yaounde, Cameroon
Health centres Rwamagana and Muhima, Kigali, Rwanda
Health centres of Samako, Kolle and Bancoumane, Bamako, Mali
Kintampo Health Research Centre, Kintampo, Brong Ahafo Region, Ghana
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.